naloxone multidose nasal spray (AP003)
/ Emergent Biosolutions
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
July 28, 2022
Pharmacokinetics (PK) and Safety of Multiple Doses of Intranasal Naloxone in Healthy Adults
(clinicaltrials.gov)
- P1 | N=24 | Completed | Sponsor: Emergent BioSolutions | Active, not recruiting ➔ Completed
Trial completion • CNS Disorders
1 to 1
Of
1
Go to page
1